speb/financial-data huggingface dataset:
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Inventory: 51900000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Invested Capital: 8386700000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Invested Capital: 8386700000.00
SUNN.SW cash_flow (annual, 2025-12-31) — Investing Cash Flow: -503800000.00
SUNN.SW cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -130800000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Investments And Advances: 30000000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 30000000.00
SUNN.SW cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
SUNN.SW cash_flow (annual, 2025-12-31) — Issuance Of Debt: 1666500000.00
SUNN.SW cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 466800000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Land And Improvements: 196000000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 196000000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Leases: 189600000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Leases: 189600000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 1095800000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 1095800000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Long Term Debt: 3950000000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 3950000000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 5045800000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 5045800000.00
SUNN.SW cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 1260800000.00
SUNN.SW cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 364800000.00
SUNN.SW cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -1344400000.00
SUNN.SW cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -436500000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Long Term Provisions: 67300000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 67300000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Minority Interest: 26200000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Minority Interest: 26200000.00
SUNN.SW income_statement (annual, 2025-12-31) — Minority Interests: -3700000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Minority Interests: -900000.00
SUNN.SW cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
SUNN.SW cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
SUNN.SW cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -240400000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Net Debt: 4064000000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Net Debt: 4064000000.00
SUNN.SW income_statement (annual, 2025-12-31) — Net Income: -112200000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Net Income: -50100000.00
SUNN.SW income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -112200000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -50100000.00
SUNN.SW income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -108500000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -49200000.00
SUNN.SW income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -112200000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -50100000.00
SUNN.SW income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -112200000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -50100000.00
SUNN.SW cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -108500000.00
SUNN.SW cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -49200000.00
SUNN.SW income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -108500000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -49200000.00
SUNN.SW income_statement (annual, 2025-12-31) — Net Interest Income: -310400000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Net Interest Income: -77500000.00
SUNN.SW cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -108600000.00
SUNN.SW cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -55600000.00
SUNN.SW cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -83600000.00
SUNN.SW cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -71700000.00
SUNN.SW income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -310400000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -77500000.00
SUNN.SW cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -175700000.00
SUNN.SW cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 106900000.00
SUNN.SW cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -4300000.00
SUNN.SW cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -200000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Net PPE: 3599500000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Net PPE: 3599500000.00
SUNN.SW cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -25000000.00
SUNN.SW cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 16100000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -2897700000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -2897700000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Non Current Accounts Receivable: 40400000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 40400000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 33300000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 33300000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 115400000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 115400000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 15300000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 15300000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 115400000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 115400000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1800000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1800000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 43200000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 43200000.00
SUNN.SW income_statement (annual, 2025-12-31) — Normalized EBITDA: 1171300000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 302000000.00
SUNN.SW income_statement (annual, 2025-12-31) — Normalized Income: -179716744.55
SUNN.SW income_statement (quarterly, 2025-12-31) — Normalized Income: -57457837.84
SUNN.SW cash_flow (annual, 2025-12-31) — Operating Cash Flow: 1215200000.00
SUNN.SW cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 461500000.00
SUNN.SW income_statement (annual, 2025-12-31) — Operating Income: 96200000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Operating Income: 12400000.00
SUNN.SW income_statement (annual, 2025-12-31) — Operating Revenue: 2854900000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Operating Revenue: 751300000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 72689152.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 72689152.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Other Current Assets: 27400000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 27400000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 387200000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 387200000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 107500000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 107500000.00
SUNN.SW income_statement (annual, 2025-12-31) — Other Gand A: 109300000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Other Gand A: 16500000.00
SUNN.SW income_statement (annual, 2025-12-31) — Other Income Expense: 85800000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Other Income Expense: 9600000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 934500000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 934500000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Other Investments: 30000000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Other Investments: 30000000.00
SUNN.SW cash_flow (annual, 2025-12-31) — Other Non Cash Items: 217000000.00
SUNN.SW cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 48400000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 600000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 600000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 230600000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 230600000.00
SUNN.SW income_statement (annual, 2025-12-31) — Other Operating Expenses: 244900000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 57200000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Other Properties: 6455200000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Other Properties: 6455200000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Other Receivables: 95400000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Other Receivables: 95400000.00
SUNN.SW income_statement (annual, 2025-12-31) — Other Special Charges: 29200000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Other Special Charges: 15200000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Payables: 340100000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Payables: 340100000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 794900000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 794900000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Prepaid Assets: 83900000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 83900000.00
SUNN.SW income_statement (annual, 2025-12-31) — Pretax Income: -128400000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Pretax Income: -55500000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Properties: 0.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
SUNN.SW income_statement (annual, 2025-12-31) — Provision For Doubtful Accounts: 19900000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Provision For Doubtful Accounts: 3800000.00
SUNN.SW cash_flow (annual, 2025-12-31) — Purchase Of Business: 0.00
SUNN.SW cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Receivables: 379100000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Receivables: 379100000.00
SUNN.SW income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 831200000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 253700000.00
SUNN.SW income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1066300000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 289300000.00
SUNN.SW cash_flow (annual, 2025-12-31) — Repayment Of Debt: -1775100000.00
SUNN.SW cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -522400000.00
SUNN.SW cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -240400000.00
SUNN.SW income_statement (annual, 2025-12-31) — Salaries And Wages: 429900000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Salaries And Wages: 107000000.00
SUNN.SW income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 185700000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 48900000.00
SUNN.SW income_statement (annual, 2025-12-31) — Selling General And Administration: 724900000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Selling General And Administration: 172400000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Share Issued: 72689152.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Share Issued: 72689152.00
SUNN.SW cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 405700000.00
SUNN.SW cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: 102000000.00
SUNN.SW cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -430700000.00
SUNN.SW cash_flow (quarterly, 2025-12-31) — Short Term Debt Payments: -85900000.00
SUNN.SW income_statement (annual, 2025-12-31) — Special Income Charges: -29200000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Special Income Charges: -15200000.00
SUNN.SW cash_flow (annual, 2025-12-31) — Stock Based Compensation: 49000000.00
SUNN.SW cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 9600000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Stockholders Equity: 4049500000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 4049500000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Tangible Book Value: -2897700000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -2897700000.00
SUNN.SW income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 12383255.45
SUNN.SW income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 942162.16
SUNN.SW income_statement (annual, 2025-12-31) — Tax Provision: -19900000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Tax Provision: -6300000.00
SUNN.SW income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.15
SUNN.SW income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.11
SUNN.SW balance_sheet (annual, 2025-12-31) — Taxes Receivable: 5500000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 5500000.00
SUNN.SW cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -33800000.00
SUNN.SW cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: -1500000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Total Assets: 11724700000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Total Assets: 11724700000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Total Capitalization: 7999500000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 7999500000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Total Debt: 5614400000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Total Debt: 5614400000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 4075700000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 4075700000.00
SUNN.SW income_statement (annual, 2025-12-31) — Total Expenses: 2887200000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Total Expenses: 776400000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 7649000000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 7649000000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 10703800000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 10703800000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 6108900000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 6108900000.00
SUNN.SW income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 96200000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 12400000.00
SUNN.SW income_statement (annual, 2025-12-31) — Total Other Finance Cost: 600000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 2100000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Total Tax Payable: 11400000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 11400000.00
SUNN.SW income_statement (annual, 2025-12-31) — Total Unusual Items: 79900000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Total Unusual Items: 8300000.00
SUNN.SW income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 79900000.00
SUNN.SW income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 8300000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 0.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 0.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Treasury Stock: 100000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 100000.00
SUNN.SW balance_sheet (annual, 2025-12-31) — Working Capital: -519200000.00
SUNN.SW balance_sheet (quarterly, 2025-12-31) — Working Capital: -519200000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — +Operating Expense: 490600000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — +Total Revenue: 722800000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 202200000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 362800000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Basic Average Shares: 70163093.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Basic EPS: -0.60
SUNN.SW cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 273200000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -82800000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -82800000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 1266900000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Capital Stock: 7400000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 151600000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 151600000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: 0.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -138100000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -83100000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 99800000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -186000000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -186000000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Changes In Cash: -121400000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Common Stock: 7400000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 4013800000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 191000000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 338400000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Current Assets: 916000000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 179600000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Current Debt: 445700000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 625300000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Current Deferred Assets: 68700000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 111000000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 111000000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1376500000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Current Provisions: 28200000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -10700000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Deferred Tax: -10700000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Depreciation: 244700000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 244700000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 244700000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 244700000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 244700000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 244700000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 665500000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 70163093.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.60
SUNN.SW income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -40300000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Non Current: 0.00
SUNN.SW income_statement (quarterly, 2026-03-31) — EBIT: 20400000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — EBITDA: 265100000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: 2000000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -200000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 1800000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — End Cash Position: 151600000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Financial Assets: 5400000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -138100000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 17000000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 4900000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 4006500000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 133500000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Goodwill: 6012700000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 6836700000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Gross PPE: 3622200000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Gross Profit: 531800000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 96100000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Interest Expense: 70500000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 70500000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Interest Income: 300000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 300000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Interest Paid Cff: -124800000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Interest Payable: 46000000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Interest Received Cfo: 0.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Inventory: 56500000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Invested Capital: 8424100000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -83100000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 32000000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 86200000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 1087300000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 3964600000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 5051900000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 86200000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -39200000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 67800000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Minority Interest: 27100000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Minority Interests: -900000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Net Debt: 4258700000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Net Income: -40300000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -40300000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -39400000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -40300000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -40300000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -39400000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -39400000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Net Interest Income: -70200000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -40500000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 47000000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -70200000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 27200000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -300000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Net PPE: 3622200000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: -87500000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -2822900000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Non Current Accounts Receivable: 33300000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 38000000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 100300000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 20800000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 100300000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 1800000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 37000000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 288200000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Normalized Income: -22133532.93
SUNN.SW cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 99800000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Operating Income: 41200000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Operating Revenue: 694400000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 72805302.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 28000000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 445700000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 58100000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Other Gand A: 24800000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Other Income Expense: -21100000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 824000000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Other Investments: 32000000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 93000000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 800000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 216700000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 56200000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Other Properties: 3622200000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Other Receivables: 45200000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Other Special Charges: 200000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Payables: 215500000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 553900000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 101800000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Pretax Income: -50100000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Provision For Doubtful Accounts: 4500000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Receivables: 413300000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 191000000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 244700000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -126700000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 27800000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Salaries And Wages: 108700000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 51700000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Selling General And Administration: 185200000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Share Issued: 72805302.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Short Term Debt Payments: -87500000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Special Income Charges: -28000000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 5800000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 4013800000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -2822900000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -4933532.93
SUNN.SW income_statement (quarterly, 2026-03-31) — Tax Provision: -10700000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.21
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 5300000.00
SUNN.SW cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: -7600000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Total Assets: 11521400000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 7978400000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Total Debt: 5677200000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 4040900000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Total Expenses: 681600000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 7480500000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 10605400000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 6104000000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 13400000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 13300000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Total Unusual Items: -23100000.00
SUNN.SW income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -23100000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 0.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 100000.00
SUNN.SW balance_sheet (quarterly, 2026-03-31) — Working Capital: -460500000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -100375600000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 11881600000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -3685600000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 60478100000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 23439100000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 21643400000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Derivative Product Liabilities: 160000000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 100900000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Financial Assets: 5500000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 9225700000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 39030900000.00
SUNPHARMA.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 21868300000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 109614500000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Hedging Assets Current: 927400000.00
SUNPHARMA.NS income_statement (annual, 2022-03-31) — Impairment Of Capital Assets: 204600000.00
SUNPHARMA.NS income_statement (annual, 2022-03-31) — Interest Income: 5533700000.00
SUNPHARMA.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 5533700000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Investmentsin Associatesat Cost: 2320600000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Investmentsin Joint Venturesat Cost: 340200000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 8621200000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 2660800000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 134990100000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 6187500000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 3433500000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Other Investments: 6846700000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Other Payable: 16559700000.00
SUNPHARMA.NS income_statement (annual, 2022-03-31) — Other Special Charges: 45150600000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 4273300000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 21156300000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 30359200000.00
SUNPHARMA.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 535400000.00
SUNPHARMA.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 535400000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 125000000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 376456500000.00
SUNPHARMA.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 32817300000.00
SUNPHARMA.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 54685600000.00
SUNPHARMA.NS balance_sheet (annual, 2022-03-31) — Work In Process: 20578000000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — +Operating Expense: 220590900000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — +Total Revenue: 432788700000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 56815200000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 114385100000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -116226300000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 11881600000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -4149300000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 12557700000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 214000000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 45444900000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 2399334970.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Basic EPS: 35.30
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 45082500000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 68196900000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -20855800000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 6879900000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 2399300000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 46237300000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 154148600000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -25188800000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 13871700000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 32365600000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -12022000000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -2158100000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -6691500000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Payable: 11823700000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -9531700000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -56618200000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -6082800000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Common Stock: 2399300000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 559953800000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Common Stock Payments: 0.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 10937400000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 119424200000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Assets: 398833400000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 1280800000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Debt: 61978800000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 63259600000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 3087100000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 199070000000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 48841100000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Depreciation: 12746600000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 25304300000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 25294300000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 25294300000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Derivative Product Liabilities: 37900000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 2399334970.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Diluted EPS: 35.30
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 84735800000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 104300000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 1324000000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — EBIT: 95804300000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — EBITDA: 121108600000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 1570700000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — End Cash Position: 46237300000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Financial Assets: 100000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 6074700000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 23760700000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 44061700000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 28737500000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -1458300000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 227100000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 28184600000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Goodwill: 83580300000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 176848700000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 118534400000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 231067500000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Gross Profit: 313364500000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Hedging Assets Current: 202300000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Impairment Of Capital Assets: 302500000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Interest Expense: 1720000000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 1720000000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Interest Income: 3845400000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 3845400000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -1324800000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 3179300000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Inventory: 105130500000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 621932600000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -79436800000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 51519600000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Investmentsin Associatesat Cost: 3474800000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Investmentsin Joint Venturesat Cost: 361600000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 81597800000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 8978400000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Liabilities Heldfor Sale Non Current: 6200000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 5599100000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 0.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 5599100000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 81597800000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -28996300000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 3836400000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 167200000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 142954800000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 33200900000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Minority Interests: -393600000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: -48413100000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 0.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Net Debt: 15741500000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 3368100000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Net Income: 84735800000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 84735800000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 85129400000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 84735800000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 84735800000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 94084300000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 85129400000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Net Interest Income: 2125400000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -14881300000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 51296600000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 52601500000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 2125400000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Net PPE: 114841200000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -20645700000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -1304900000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 383105100000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 5698700000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 35189200000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 316900000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 3261900000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 26252900000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 122923100000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Normalized Income: 86386834676.35
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 49593300000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Operating Income: 92773600000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Operating Revenue: 432788700000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 2399334970.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: 5666900000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 862500000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 4860000000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 557554500000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 93268400000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -2276100000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 51576970000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 129500000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 796300000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 37368700000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Payable: 13469600000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Properties: 103903800000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 424100000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 107911300000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Other Special Charges: -208700000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Payables: 70389100000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 4702700000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 23337400000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Pretax Income: 94084300000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 2070500000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Purchase Of Business: -48413100000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -225338400000.00
SUNPHARMA.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -20855800000.00
SUNPHARMA.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 36095000000.00
SUNPHARMA.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 119424200000.00